EVALUATION OF PULSE OXYMETER PARAMETER TO PREDICT REQUIREMENT OF DRUGS TO INCREASE BLOOD PRESSURE IN PATIENTS WITH SEPSIS
- Conditions
- Sepsis, unspecified organism,
- Registration Number
- CTRI/2023/02/049572
- Lead Sponsor
- Indraprastha Apollo Hospitals
- Brief Summary
We will study patients with sepsis our pulse oxymeter derived parameter - perfusion index in observational manner as a prospective study at Indraprastha Apollo New Delhi. The patients will receive adequate fluid resuscitation (30 ml/kg) as part of sepsis treatment as per standard guidelines of care. After that perfusion index will be observed. At 6 hour interval , we will observe perfusion index again. We will follow these patients in course of stay and see for how many patients required vasopressor therapy in initial 24 hours (primary objective) and what was the outcome of patient (secondary objective).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 35
Age> 18 years Clinically suspected sepsis Adequate Fluid Resuscitation (30ml/kg).
Age < 18 years Pregnant Females inadequate fluid resuscitation (<30ml/kg) Already receiving vasopressor therapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare perfusion index to arterial lactate levels at T0 and T6 hours as predictor of vasopressor requirement in first 24 hour Compare perfusion index to arterial lactate levels at T0 and T6 hours as predictor of vasopressor requirement in first 24 hour
- Secondary Outcome Measures
Name Time Method final outcome of patients with sepsis (Discharged / Death) 0-28 days
Trial Locations
- Locations (1)
Indraprastha Apollo Hospitals
🇮🇳South, DELHI, India
Indraprastha Apollo Hospitals🇮🇳South, DELHI, IndiaDr Jaydeep Narendrabhai AnadkatPrincipal investigator8866487547jaydeepanadkat@gmail.com